£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 88 days · 88 data points

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 12 August 2026 02 September 2026 24 September 2026 16 October 2026 07 November 2026
View at Amazon ↗

Price data checked 3 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 88 days • 1 price levels

Days at Price
88 days 0 22 44 66 88 £515 Days at Price

Price Analysis

Most common price: £515 (88 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 88 days

Description

This market study provides a comprehensive outlook for targeted therapy liver cancer drugs in India from 2023 to 2028. The report focuses on latent demand, providing potential industry earnings (P.I.E.) estimates in millions of U.S. dollars. Data is detailed across states, union territories, and over 4,900 cities throughout India. By offering the percent share of each city relative to its state, union territory, and the country as a whole, this research provides comparative benchmarks for market analysis. These statistics serve as a practical tool for developing effective distribution and sales force strategies within the Indian pharmaceutical sector.

Key Features

Provides latent demand outlook for targeted therapy liver cancer drugs in India from 2023 to 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars.

Covers data for over 4,900 cities across various states and union territories in India.

Reports percent share for each city relative to its state, union territory, and India as a whole.

Offers comparative benchmarks to help gauge city performance against others for better market analysis.

Supports the development of distribution and sales force strategies through statistical data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

Targeted Therapy Liver Cancer Drugs Outlook 2023-2028
99% match

Targeted Therapy Liver Cancer Drugs Outlook 2023-2028

£520.00 06 Nov 2026
World Outlook: Targeted Therapy Liver Cancer Drugs 2025-2030
99% match

World Outlook: Targeted Therapy Liver Cancer Drugs 2025-2030

£790.00 02 Nov 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
99% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 06 Nov 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan
99% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan

£495.00 05 Nov 2026
US Liver Cancer Drug Outlook 2016-2021 Econometric Study
98% match

US Liver Cancer Drug Outlook 2016-2021 Econometric Study

£595.00 01 Nov 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
98% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026
US Targeted Therapy Liver Cancer Drug Outlook 2023-2028
98% match

US Targeted Therapy Liver Cancer Drug Outlook 2023-2028

£490.00 07 Nov 2026
World Outlook for Liver Cancer Therapeutics 2025-2030
98% match

World Outlook for Liver Cancer Therapeutics 2025-2030

Price unavailable
India Cancer Supportive Care Drugs Outlook 2023-2028
98% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City
98% match

The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City

£995.00 29 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
98% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
98% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 02 Nov 2026
2023-2028 US Cancer Screening Outlook - Market Study
97% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
Cancer Diagnostics Lab Test Outlook in India 2023-2028
97% match

Cancer Diagnostics Lab Test Outlook in India 2023-2028

£515.00 02 Nov 2026
World Outlook for Liver Cancer Diagnostics 2025-2030
97% match

World Outlook for Liver Cancer Diagnostics 2025-2030

Price unavailable
The 2023-2028 Outlook for Liver Health Supplements in India
97% match

The 2023-2028 Outlook for Liver Health Supplements in India

£515.00 03 Sep 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 27 Oct 2026